Cargando…

Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a positive-sense, single-stranded RNA virus that causes the potentially lethal Covid-19 respiratory tract infection. It does so by binding to host cell angiotensin converting enzyme 2 (ACE2) receptors, leading to endocytosis with th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poduri, Ramarao, Joshi, Gaurav, Jagadeesh, Gowraganahalli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science Ltd 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375293/ https://www.ncbi.nlm.nih.gov/pubmed/32711111 http://dx.doi.org/10.1016/j.cellsig.2020.109721

Ejemplares similares

Recent efforts for drug identification from phytochemicals against SARS-CoV-2: Exploration of the chemical space to identify druggable leads
por: Joshi, Gaurav, et al.
Publicado: (2021)

Exploring insights of hydroxychloroquine, a controversial drug in Covid-19: An update
por: Joshi, Gaurav, et al.
Publicado: (2021)

Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy
por: Joshi, Gaurav, et al.
Publicado: (2022)

Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?
por: Joshi, Gaurav, et al.
Publicado: (2021)

Exploring the magic bullets to identify Achilles’ heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update
por: Thakur, Shikha, et al.
Publicado: (2021)

Exploring the Potential Role of Theaflavin-3,3′-Digallate in Inhibiting Various Stages of SARS-CoV-2 Life Cycle: An In-Silico Approach
por: Jain, Manav, et al.
Publicado: (2022)

The basic concepts of scientific research and scientific communication
por: Balakumar, Pitchai, et al.
Publicado: (2012)

Drug discovery and development targeting the life cycle of SARS-CoV-2
por: Su, Haixia, et al.
Publicado: (2021)

Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2
por: Sami, Neha, et al.
Publicado: (2021)

The critical steps for successful research: The research proposal and scientific writing: (A report on the pre-conference workshop held in conjunction with the 64(th) annual conference of the Indian Pharmaceutical Congress-2012)
por: Balakumar, Pitchai, et al.
Publicado: (2013)

Potential therapeutic targets and promising drugs for combating SARS‐CoV‐2
por: Zhou, Hong, et al.
Publicado: (2020)

Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
por: Sadegh, Sepideh, et al.
Publicado: (2020)

Increased contractile responses to 5-hydroxytryptamine and Angiotensin II in high fat diet fed rat thoracic aorta
por: Ghatta, Srinivas, et al.
Publicado: (2004)

Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs
por: Hosseini, Maryam, et al.
Publicado: (2021)

Tackling SARS-CoV-2: proposed targets and repurposed drugs
por: Joshi, Siddhi, et al.
Publicado: (2020)

Paxlovid: A promising drug for the challenging treatment of SARS-COV-2 in the pandemic era
por: Niraj, Niraj, et al.
Publicado: (2022)

Computational and theoretical exploration for clinical suitability of Remdesivir drug to SARS-CoV-2
por: Nayeem, Shaik Mahammad, et al.
Publicado: (2021)

Promising inhibitors targeting M(pro): an ideal strategy for anti-SARS-CoV-2 drug discovery
por: Chen, Yi, et al.
Publicado: (2020)

Promising anti-SARS-CoV-2 drugs by effective dual targeting against the viral and host proteases
por: Elseginy, Samia A., et al.
Publicado: (2021)

The promising use of nano-molecular imprinted templates for improved SARS-CoV-2 detection, drug delivery and research
por: Nahhas, Alaa F., et al.
Publicado: (2021)

Possible therapeutic targets and promising drugs based on unsymmetrical hetaryl-substituted porphyrins to combat SARS-CoV-2
por: Gubarev, Yury A., et al.
Publicado: (2021)

Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors
por: Mushebenge, Aganze Gloire-Aimé, et al.
Publicado: (2023)

Centrosome cycle studies reveal promising candidates for anti-cancer drug design
por: Schmeichel, Karen L
Publicado: (2003)

Sterol targeting drugs reveal life cycle stage-specific differences in trypanosome lipid rafts
por: Sharma, Aabha I., et al.
Publicado: (2017)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Molecular insights of hyaluronic acid-hydroxychloroquine conjugate as a promising drug in targeting SARS-CoV-2 viral proteins
por: Thirumalaisamy, R., et al.
Publicado: (2021)

Quercetin: A promising drug candidate against the potential SARS-CoV-2-Spike mutants with high viral infectivity
por: Pan, Boyu, et al.
Publicado: (2023)

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
por: Tummino, Tia A., et al.
Publicado: (2021)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Viroporins: Structure, function, and their role in the life cycle of SARS-CoV-2
por: Breitinger, Ulrike, et al.
Publicado: (2022)

Drug Discovery Strategies for SARS-CoV-2
por: Shyr, Zeenat A., et al.
Publicado: (2020)

Immunomodulatory Drugs in the Management of SARS-CoV-2
por: Burrage, Daniel R., et al.
Publicado: (2020)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

Correction to: Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

A 3D Structural SARS-CoV-2-Human Interactome to Explore Genetic and Drug Perturbations
por: Wierbowski, Shayne D., et al.
Publicado: (2021)

Artemisitene: a promising natural drug candidate with various biological activities needs to confirm the interactional targets
por: Lin, Xian, et al.
Publicado: (2023)

Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review
por: Al-Horani, Rami A., et al.
Publicado: (2020)

Extracellular vesicles: A promising therapy against SARS-CoV-2 infection
por: Leyfman, Yan, et al.
Publicado: (2023)

Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2
por: Fan, Shiyong, et al.
Publicado: (2020)

Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2
por: Jena, N.R.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l98hsppv980l4s9845i9vim733